Jasper Therapeutics, Inc. (JSPRW)

USD 0.22

(26.64%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - - -
Cost of Revenue 1.1 Million 1.31 Million 566 Thousand 21 Thousand -
Gross Profit -1.1 Million -1.31 Million -566 Thousand -21 Thousand -
Operating Expenses 68.86 Million 51.19 Million 36.83 Million 20.68 Million 4.45 Million
Selling, General and Administrative Expenses 17.07 Million 16.56 Million 11.41 Million 4.8 Million 1.09 Million
Research and Development Expenses 51.78 Million 34.62 Million 25.42 Million 15.88 Million 3.61 Million
Other Expenses - 586 Thousand -80 Thousand -111 Thousand -
Cost and Expenses 68.86 Million 51.19 Million 36.83 Million 20.68 Million 4.45 Million
Operating Income -68.86 Million -51.19 Million -36.83 Million -20.68 Million -4.71 Million
Interest Expense - - - - -
Income Tax Expense -1.62 Million -13.51 Million -6.65 Million -38.45 Thousand -277.00
Earnings before Tax -66.09 Million -37.68 Million -30.63 Million -31.66 Million -4.98 Million
Net Income -64.46 Million -24.17 Million -23.98 Million -31.66 Million -4.98 Million
Earnings Per Share Basic -6.18 -6.63 -21.05 -114.30 -
Earnings Per Share Diluted -6.18 -6.63 -21.05 -114.30 -
Weighted Average Shares Outstanding 10.43 Million 3.64 Million 1.13 Million 277.07 Thousand -
Weighted Average Shares Outstanding (Diluted) 10.43 Million 3.64 Million 1.13 Million 277.07 Thousand -
Gross Margin - - - - -
EBIT Margin - - - - -
Profit Margin - - - - -
EBITDA -64.98 Million -38.21 Million -31.16 Million -31.94 Million -277 Thousand
Earnings Before Tax Margin - - - - -

Income Statement Charts